Pandemic-Related Disruptions and Hepatocellular Carcinoma Surveillance in Safety-Net Settings - Top-Institutions - MDSpire

Pandemic-Related Disruptions and Hepatocellular Carcinoma Surveillance in Safety-Net Settings

By
Robert J. Wong
Patricia Jones
Bolin Niu
Paulo Pinheiro
Mae Thamer
Onkar Kshirsagar
Yi Zhang
Ronnie Fass
Daniela Prieto-Bello
Lisa Quirk
George Therapondos
Amit G. Singal
Mandana Khalili
May 22, 2026
0 min

Jama Network Open

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

San Francisco Community Health Network

San Francisco, CA
Key Differentiators
- Hepatology
#2

Zuckerberg San Francisco General Hospital

San Francisco, CA
Key Differentiators
- Hepatology
#3

Ochsner Health System

New Orleans, LA
Key Differentiators
- Hepatology
#4

Parkland Health and Hospital System

Dallas, TX
Key Differentiators
- Hepatology
#5

Jackson Memorial Health System

Miami, FL
Key Differentiators
- Hepatology

Original Source(s)

Jama Network Open

Pandemic-Related Disruptions and Hepatocellular Carcinoma Surveillance in Safety-Net Settings

by Robert J. Wong, Patricia Jones, Bolin Niu, Paulo Pinheiro, Mae Thamer, Onkar Kshirsagar, Yi Zhang, Ronnie Fass, Daniela Prieto-Bello, Lisa Quirk, George Therapondos, Amit G. Singal, Mandana Khalili
May 22, 2026

Related Content

Frontiers In Oncology

Management of toxicities from antibody – drug conjugates in breast cancer

by Ajay Gogia
May 29, 2026

Blood Cancer Journal

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Nature Cancer

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2